Direct antiviral drugs and blocking monoclonal antibodies as the basis of etiotropic therapy of a novel coronavirus infection
At the beginning of 2020, a pandemic of a novel coronavirus infection was declared in the world. Since the beginning of the pandemic, the search for drugs for etiotropic therapy as the basis for the treatment of the infectious process has begun. The review provides data on the application points of...
Saved in:
| Main Author: | V. B. Musatov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Journal Infectology
2022-10-01
|
| Series: | Журнал инфектологии |
| Subjects: | |
| Online Access: | https://journal.niidi.ru/jofin/article/view/1393 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience in using specific recombinant monoclonal antibodies in comorbid patients with coronavirus infection
by: S. A. Sokotun, et al.
Published: (2024-12-01) -
In vitro expression of SARS coronavirus (SARS-CoV) nucleocapsid protein and examination of the function of monoclonal antibody induced by the expressed protein
by: CHEN Hong-xun, et al.
Published: (2005-03-01) -
Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2024-10-01) -
Corrigendum: Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2025-02-01) -
Emergency department implementation of monoclonal antibody infusion for the treatment of coronavirus disease 2019: A template for rapid deployment
by: Thomas J. Woltemate, et al.
Published: (2021-10-01)